Aromatase Inhibitors Linked to Higher Cardiovascular Risk
A retrospective study in Cardio-Oncology finds aromatase inhibitors are associated with a modestly higher hazard of composite cardiovascular outcomes compared ...
A retrospective study in Cardio-Oncology finds aromatase inhibitors are associated with a modestly higher hazard of composite cardiovascular outcomes compared ...
A retrospective study finds no significant difference in recurrence-free survival between chemoendocrine therapy and tamoxifen plus ovarian function suppression in ...
Oral administration of p-propoxybenzoic acid delayed tumor onset and reduced tumor growth in female rats with chemically induced breast cancer, ...
A study in Cell Biology and Toxicology shows that a darunavir-analogue precursor enhances tamoxifen response in breast cancer by inducing ...
A national study of Medicaid beneficiaries with breast cancer found that nominal prescription co-payments under eight dollars were not associated ...
Sequential estrogen-progesterone exposure that mimics menstruation significantly worsened uterine fibrosis in mice with tamoxifen-induced adenomyosis, and the iron chelator deferoxamine ...
A cross-sectional study of Reddit discussions found that side effects were the most common topic among patients sharing experiences with ...
A retrospective cohort study of women with ER-positive breast cancer and cardiovascular risk factors found that aromatase inhibitor therapy was ...
A new review explains how gut microbial enzymes, bioaccumulation, and enterohepatic recycling can activate, inactivate, or toxify drugs, while cautioning ...
Tamoxifen has been a cornerstone of breast cancer therapy for more than four decades, yet the drug still carries a ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine